212 related articles for article (PubMed ID: 24679900)
1. Survival in Parkinson's disease. Relation with motor and non-motor features.
de Lau LM; Verbaan D; Marinus J; van Hilten JJ
Parkinsonism Relat Disord; 2014 Jun; 20(6):613-6. PubMed ID: 24679900
[TBL] [Abstract][Full Text] [Related]
2. Parkinson's disease progression at 30 years: a study of subthalamic deep brain-stimulated patients.
Merola A; Zibetti M; Angrisano S; Rizzi L; Ricchi V; Artusi CA; Lanotte M; Rizzone MG; Lopiano L
Brain; 2011 Jul; 134(Pt 7):2074-84. PubMed ID: 21666262
[TBL] [Abstract][Full Text] [Related]
3. What predicts mortality in Parkinson disease?: a prospective population-based long-term study.
Forsaa EB; Larsen JP; Wentzel-Larsen T; Alves G
Neurology; 2010 Oct; 75(14):1270-6. PubMed ID: 20921512
[TBL] [Abstract][Full Text] [Related]
4. Motor and cognitive outcome in patients with Parkinson's disease 8 years after subthalamic implants.
Fasano A; Romito LM; Daniele A; Piano C; Zinno M; Bentivoglio AR; Albanese A
Brain; 2010 Sep; 133(9):2664-76. PubMed ID: 20802207
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for hallucinations in Parkinson's disease: results from a large prospective cohort study.
Zhu K; van Hilten JJ; Putter H; Marinus J
Mov Disord; 2013 Jun; 28(6):755-62. PubMed ID: 23520046
[TBL] [Abstract][Full Text] [Related]
6. Motor and non-motor features of Parkinson's disease that predict persistent drug-induced Parkinsonism.
Morley JF; Pawlowski SM; Kesari A; Maina I; Pantelyat A; Duda JE
Parkinsonism Relat Disord; 2014 Jul; 20(7):738-42. PubMed ID: 24742370
[TBL] [Abstract][Full Text] [Related]
7. Physical assessment as a predictor of mortality in people with Parkinson's disease: a study over 7 years.
Gray WK; Hildreth A; Bilclough JA; Wood BH; Baker K; Walker RW
Mov Disord; 2009 Oct; 24(13):1934-40. PubMed ID: 19672988
[TBL] [Abstract][Full Text] [Related]
8. The relation between cognition and motor dysfunction in drug-naive newly diagnosed patients with Parkinson's disease.
Domellöf ME; Elgh E; Forsgren L
Mov Disord; 2011 Oct; 26(12):2183-9. PubMed ID: 21661051
[TBL] [Abstract][Full Text] [Related]
9. Gender differences in motor and non-motor symptoms among Sardinian patients with Parkinson's disease.
Solla P; Cannas A; Ibba FC; Loi F; Corona M; Orofino G; Marrosu MG; Marrosu F
J Neurol Sci; 2012 Dec; 323(1-2):33-9. PubMed ID: 22935408
[TBL] [Abstract][Full Text] [Related]
10. Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation.
Thobois S; Ardouin C; Lhommée E; Klinger H; Lagrange C; Xie J; Fraix V; Coelho Braga MC; Hassani R; Kistner A; Juphard A; Seigneuret E; Chabardes S; Mertens P; Polo G; Reilhac A; Costes N; LeBars D; Savasta M; Tremblay L; Quesada JL; Bosson JL; Benabid AL; Broussolle E; Pollak P; Krack P
Brain; 2010 Apr; 133(Pt 4):1111-27. PubMed ID: 20237128
[TBL] [Abstract][Full Text] [Related]
11. Predictors of dementia in Parkinson's disease; findings from a 5-year prospective study using the SCOPA-COG.
Zhu K; van Hilten JJ; Marinus J
Parkinsonism Relat Disord; 2014 Sep; 20(9):980-5. PubMed ID: 25024059
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors for early mortality in Parkinson's disease.
Oosterveld LP; Allen JC; Reinoso G; Seah SH; Tay KY; Au WL; Tan LC
Parkinsonism Relat Disord; 2015 Mar; 21(3):226-30. PubMed ID: 25572499
[TBL] [Abstract][Full Text] [Related]
13. Cognitive Impairment and Mortality in a Population-Based Parkinson's Disease Cohort.
Keener AM; Paul KC; Folle A; Bronstein JM; Ritz B
J Parkinsons Dis; 2018; 8(2):353-362. PubMed ID: 29843251
[TBL] [Abstract][Full Text] [Related]
14. Mortality from Parkinson's disease: a population-based prospective study (NEDICES).
Posada IJ; Benito-León J; Louis ED; Trincado R; Villarejo A; Medrano MJ; Bermejo-Pareja F
Mov Disord; 2011 Dec; 26(14):2522-9. PubMed ID: 21915906
[TBL] [Abstract][Full Text] [Related]
15. Testing an aetiological model of visual hallucinations in Parkinson's disease.
Gallagher DA; Parkkinen L; O'Sullivan SS; Spratt A; Shah A; Davey CC; Bremner FD; Revesz T; Williams DR; Lees AJ; Schrag A
Brain; 2011 Nov; 134(Pt 11):3299-309. PubMed ID: 21921019
[TBL] [Abstract][Full Text] [Related]
16. Impaired self-awareness of motor deficits in Parkinson's disease: association with motor asymmetry and motor phenotypes.
Maier F; Prigatano GP; Kalbe E; Barbe MT; Eggers C; Lewis CJ; Burns RS; Morrone-Strupinsky J; Moguel-Cobos G; Fink GR; Timmermann L
Mov Disord; 2012 Sep; 27(11):1443-7. PubMed ID: 22711290
[TBL] [Abstract][Full Text] [Related]
17. Explaining freezing of gait in Parkinson's disease: motor and cognitive determinants.
Vercruysse S; Devos H; Munks L; Spildooren J; Vandenbossche J; Vandenberghe W; Nieuwboer A; Heremans E
Mov Disord; 2012 Nov; 27(13):1644-51. PubMed ID: 23115014
[TBL] [Abstract][Full Text] [Related]
18. Relationship between cognitive dysfunction and behavioural symptoms in Nigerian patients with Parkinson's disease no dementia.
Ojagbemi A
J Parkinsons Dis; 2013 Jan; 3(3):293-300. PubMed ID: 23963316
[TBL] [Abstract][Full Text] [Related]
19. The influence of age and approaching death on the course of nondopaminergic symptoms in Parkinson's disease.
van Rooden SM; Verbaan D; Stijnen T; Marinus J; van Hilten JJ
Parkinsonism Relat Disord; 2016 Mar; 24():113-8. PubMed ID: 26774535
[TBL] [Abstract][Full Text] [Related]
20. [Psychoses in patients with Parkinson's disease; their frequency, phenomenology, and clinical correlates].
Kashihara K; Ohno M; Katsu Y
Rinsho Shinkeigaku; 2005 Jan; 45(1):1-5. PubMed ID: 15714992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
